Published in
American Society for Clinical Investigation, JCI Insight, 22(7), 2022
DOI: 10.1172/jci.insight.159419
Links
Tools
Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanism
Journal article published in 2022 by
Wade R. Gutierrez 
,
Amanda Scherer,
Jeffrey D. Rytlewski,
Emily A. Laverty ,
Alexa P. Sheehan ,
Gavin R. McGivney ,
Qierra R. Brockman ,
Vickie Knepper-Adrian,
Grace A. Roughton ,
Dawn E. Quelle ,
David J. Gordon ,
Varun Monga ,
Rebecca D. Dodd
,
Amanda Scherer,
Jeffrey D. Rytlewski,
Emily A. Laverty ,
Alexa P. Sheehan ,
Gavin R. McGivney ,
Qierra R. Brockman ,
Vickie Knepper-Adrian,
Grace A. Roughton ,
Dawn E. Quelle ,
David J. Gordon ,
Varun Monga ,
Rebecca D. Dodd
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 